Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CBOE✓SelectedUSD · CBOEGSK vs CBOE performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs CBOE

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+44.4%
CBOE return
+202.6%
Excess return
-158.3%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioCBOEExcessAlpha
1D+0.5%+1.8%-1.2%+0.3%
7D+1.1%+6.3%-5.1%+0.4%
30D+6.3%+24.9%-18.6%+3.3%
3M+1.8%+28.5%-26.6%-1.5%
6M+1.7%+2.9%-1.2%+1.6%
YTD+6.5%+50.7%-44.1%-0.8%
1Y+9.5%+45.5%-36.0%+2.6%
3Y+65.3%+116.3%-51.0%+41.4%
All+44.4%+202.6%-158.3%+9.8%

Cumulative growth

Daily Returns

Daily percentage return beside CBOE.

Daily Out/Under-Performance

Portfolio return minus CBOE return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CBOE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded CBOE wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling